Cafepharma Today

May 27 2025 - Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Eli Lilly expands pain pipeline with acquisition of SiteOne Therapeutics
Rocket crashes as gene therapy patient dies, FDA imposes hold
Biogen maps out $1B biobucks deal with RNAi-focused City Therapeutics
Trump taps Oz to lead drug pricing negotiations as customs warns against import violations
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Moment of Truth for Health Care
Yahoo/Morningstar
Monday, December 7, 2009 - 12:21pm
tags:
Merck, healthcare reform, GSK, Express Scripts
Introducing the $30,000 Per Month Cancer Drug
WSJ Online
Monday, December 7, 2009 - 12:20pm
tags:
cancer, Folotyn, lymphoma, Allos
Elan: J&J unit seeks Europe schizophrenia-drug OK
Marketwatch
Monday, December 7, 2009 - 12:19pm
tags:
Europe, schizophrenia, Elan, JNJ
Court Agrees Solvay Whistleblower Suit Should Be Tossed
Pharmalot
Monday, December 7, 2009 - 11:35am
tags:
Solvay, whistleblowers
Novo Starts First Insulin Pill Test in Bid to Replace Injection
Bloomberg
Monday, December 7, 2009 - 11:33am
tags:
Novo Nordisk, insulin, diabetes
Cephalon’s Treanda Poised for 10-Fold Sales Surge
Bloomberg
Monday, December 7, 2009 - 11:32am
tags:
Cephalon, Treanda, cancer
France Takes Another Shot at Combating H1N1 Threat
WSJ Online
Monday, December 7, 2009 - 11:31am
tags:
France, vaccines, swine flu, H1N1
Blood Thinner Battle Heats Up
Forbes
Monday, December 7, 2009 - 11:24am
tags:
Boehringer Ingelheim, JNJ, blood thinners
Cytokinetics Announces Clinical Trial Data Regarding SB-743921 Presented at the 2009 American Society of Hematology Annual Meeting and Exposition
Yahoo/MarketWire
Sunday, December 6, 2009 - 12:20pm
tags:
Cytokinetics, Hodgkin's lymphoma
Better Biotech Buy: Celgene or Genzyme?
Motley Fool
Sunday, December 6, 2009 - 12:18pm
tags:
Celgene, Genzyme
Carfilzomib Safety Data From Ongoing Phase 2b Pivotal Trial in Relapsed and Refractory Multiple Myeloma Show Promising Safety and Tolerability
Trading Markets
Sunday, December 6, 2009 - 12:17pm
tags:
ONYX Pharmaceuticals, Carfilzomib, Multiple Myeloma
AstraZeneca Could Face 6,000 Lawsuits over Seroquel Side Effects
Lawyers and Settlements
Sunday, December 6, 2009 - 11:29am
tags:
AstraZeneca, Seroquel
Eshoo bill huge boon for Silicon Valley biotech
San Francisco Gate
Sunday, December 6, 2009 - 11:27am
tags:
biotech, Eschoo bill
Taro's first branded drug gets FDA trial nod
Globes, Israel
Sunday, December 6, 2009 - 11:17am
tags:
Taro, essential tremor, T2000
Teva seen among leaders for Ratiopharm
Globes, Israel
Sunday, December 6, 2009 - 11:16am
tags:
Teva Pharmaceuticals, Ratiopharm
VELCADE(R) (Bortezomib) for Injection Based Regimens Result in Lower Costs and Less Patient Burden Than Other Commonly Used Multiple Myeloma Treatment Regimens
istockanalyst
Sunday, December 6, 2009 - 11:09am
tags:
Velcade, Multiple Myeloma
GSK shops around for $3bn worth of acquisitions
Guardian, UK
Sunday, December 6, 2009 - 11:06am
tags:
GSK
Amira Pharmaceuticals Announces Initial Positive Phase 1 Clinical Data for AM461, A Back-Up to Amira's Lead DP2 Antagonist, AM211
Pipeline Review
Sunday, December 6, 2009 - 10:53am
tags:
Amira, asthma, COPD
Bristol-Myers Squibb and Mead Johnson Announce Amendment and Extension of Exchange Offer
Yahoo/BusinessWire
Saturday, December 5, 2009 - 12:18pm
tags:
Bristol-Myers Squibb, Mead Johnson
Cyclacel Reports Phase 2 Sapacitabine Data in Acute Myeloid Leukemia and Myelodysplastic Syndromes at 2009 ASH Annual Meeting
Yahoo/GlobeNewsWire
Saturday, December 5, 2009 - 12:16pm
tags:
Cyclacel, Sapacitabine, acute myeloid leukemia, myelodysplastic syndrome

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.